SAN DIEGO, Calif.--Acadia Pharmaceuticals, a privately held genomics drug discovery company headquartered here, with chemical research facilities in Copenhagen, raised nearly $10.7 million through a private placement of stock in late August. ABN AMRO Ventures, Amsterdam, led the financing, which also included participation from leading Swedish institutional investors. Danish institutional investors included previous Acadia investors Dansk Kapitalanlaeg, Municipal Employees Life Insurance, and LD Pensions.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.